By Jayne Leonard Reviewed by Nancy Moyer, MD High cholesterol is a risk factor for heart disease and stroke. Diet and other lifestyle choices are often to blame for high cholesterol. But sometimes medical conditions, such as a thyroid disorder, are at fault. Producing too many or too few thyroid hormones increases the risk of...
Post
Off Your Mental Game? You Could Be Mildly Dehydrated
Was it hard to concentrate during that long meeting? Or, does the crossword seem a little tougher? You could be mildly dehydrated. Unless you replenish fluids, just an hour’s hike in the heat, or a 30-minute run, might be enough to get mildly dehydrated, scientists say. A growing body of evidence finds that being just...
Post
Contact sports increase Parkinson’s disease risk
By Maria Cohut Fact checked by Jasmin Collier Injuries from playing contact sports, such as rugby, boxing, and martial arts, have been linked to a heightened risk of dementia. A new study now says that contact sports may actually lead to other neurodegenerative diseases, and it explains why. A new study argues that contact sports...
Post
Can too much vitamin D hurt you?
Few foods contain vitamin D, so many people take supplements. Long-term use of these supplements can cause some adverse side effects, though this is relatively rare. Vitamin D is fundamental in supporting several bodily processes, including: the absorption and regulation of calcium, magnesium, and phosphate the hardening, growth, and remodeling of bones cellular growth and remodeling immune function...
Post
Just two weeks’ inactivity can trigger diabetic symptoms in vulnerable patients: Research
MCMASTER UNIVERSITY HAMILTON, ON, July 31, 2018 – Just two weeks without much activity can have a dramatic impact on health from which it is difficult to recover, according to researchers who studied overweight older adults at risk of developing Type 2 diabetes. IMAGE: MCMASTER UNIVERSITY RESEARCHERS STUART PHILIPS, LEFT, AND CHRIS MCGLORY, CENTRE, WORK WITH...
Post
Heat therapy boosts mitochondrial function in muscles
Increased capability of cells’ energy centers could help treat heart disease, diabetes AMERICAN PHYSIOLOGICAL SOCIETY Rockville, Md. (July 31, 2018)–A new study finds that long-term heat therapy may increase mitochondrial function in the muscles. The discovery could lead to new treatments for people with chronic illness or disease. The study–the first of its kind in humans–is...
Post
MARRVEL: Integration of Human and Model Organism Genetic Resources to Facilitate Functional Annotation of the Human Genome
One major challenge encountered with interpreting human genetic variants is the limited understanding of the functional impact of genetic alterations on biological processes. Furthermore, there remains an unmet demand for an efficient survey of the wealth of information on human homologs in model organisms across numerous databases. To efficiently assess the large volume of publically...
Post
Breathalyser detects Parkinson’s disease with more than 80% accuracy in at-risk people: Early diagnosis helps to prevent devastating symptoms
Parkinson’s occurs when nerve cells that produce the chemical dopamine die By the time of diagnosis, most of these nerve cells have already died This limits patients’ treatment options and causes their symptoms to worsen Device is better than standard diagnosis smell test, which is 73% accurate Parkinson’s affects one in 500 people in the...
Post
Antiques dealer, 48, who was forced to give up work for 8 YEARS because of her crippling back pain finds a cure – using a device designed for HORSES
Victoria Rockliffe, 48, was first diagnosed with a prolapsed disc back in 2010 Doctors gave her codeine, morphine and a spinal procedure – but none worked In desperation, she resorted to a pioneering £250 device called Arc4Health Ms Rockcliffe, from East Sussex, is now set to return to work as an antique dealer A mother...
Post
Ivosidenib earns FDA approval against IDH1+ acute myeloid leukemia
Clinical trials at University of Colorado Cancer Center and elsewhere now result in the drug ivosidenib earning approval from the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (R/R AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation. Ivosidenib, an oral, targeted inhibitor of the IDH1...